相关实验视频

Updated: Jul 9, 2025

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

肉质菌病毒抗性蛋白A:一种表达在异常性炎症性肌肉病的表达的研究

Jariya Waisayarat¹, Phumin Wongsuwan¹, Kiarttiyot Tuntiseranee²

¹Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Journal of inflammation research

|November 29, 2023

概括

肉质菌病毒抗性蛋白A (MxA) 是高度特定的诊断皮肤肌炎在异常发炎性肌病 (IIM). 这一发现表明,MxA免疫组织化学可以帮助区分皮肤肌炎与其他IIM亚型.

科学领域:

免疫学免疫学免疫学
神经学神经学
病理学病理学病理学

背景情况:

异常性炎症性肌肉病变 (IIM) 是一种自身免疫性疾病,主要影响靠近肌肉.
关键的亚型包括皮肤肌炎,多肌炎和包容体肌炎.
在皮肤肌炎中观察到过度表达的肉质菌病毒抗性蛋白A (MxA),但在其他IIM中很少见.

研究的目的:

在肌肉活检中评估质MxA表达.
为了确定MxA在识别IIM亚型的诊断价值.

主要方法:

审查了138个被诊断为IIM或其他肌肉病变的肌肉活检样本 (2011-2020年).
在所有样本上进行了MxA免疫组织化学染色.
分析了MxA表达差异,并计算了诊断灵敏度和特异性.

主要成果:

在11.6%的标本中,MxA蛋白呈阳性.
所有的MxA阳性皮肤肌炎病例都显示出周围血管染色.
皮肤肌肉炎的MxA表达显著高于其他IIM亚型 (p<0.001).

结论:

MxA免疫组织化学表明对皮肤肌炎具有很高的特异性.
考虑将MxA染色添加到常规炎性肌肉病活检面板中.
建议谨慎解释MxA表达,以防止诊断错误.

关键词:

皮肤质神经炎 (dermatomyositis) 是一种疾病.异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathies) 是一种异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathies) 的一种疾病.肌肉活组织活检肌肉活检抗菌病毒耐药性蛋白质A

更多相关视频

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...